STING1 and neoplasm: To address this, the STING agonist, cGAMP, was encapsulated into DMPtNPS (DMPtNPS@cGAMP) in a CT26 tumor-bearing mouse model, which resulted in improved control tumor growth in combination with radiotherapy, with a sustained complete response of 30%.